APA (7th ed.) Citation

Shingina, A., Hashim, A. M., Haque, M., Suen, M., Yoshida, E. M., Gill, S., . . . Weiss, A. A. In a ‘Real-World’, Clinic-Based Community Setting, Sorafenib Dose of 400 mg/day is as Effective as Standard Dose of 800 mg/day in Patients with Advanced Hepatocellular Carcimona, with Better Tolerance and Similar Survival. Wiley.

Chicago Style (17th ed.) Citation

Shingina, Alexandra, Al Moutaz Hashim, Mazhar Haque, Michael Suen, Eric M. Yoshida, Sharlene Gill, Fergal Donnellan, and Alan A. Weiss. In a ‘Real-World’, Clinic-Based Community Setting, Sorafenib Dose of 400 Mg/day Is as Effective as Standard Dose of 800 Mg/day in Patients with Advanced Hepatocellular Carcimona, with Better Tolerance and Similar Survival. Wiley.

MLA (9th ed.) Citation

Shingina, Alexandra, et al. In a ‘Real-World’, Clinic-Based Community Setting, Sorafenib Dose of 400 Mg/day Is as Effective as Standard Dose of 800 Mg/day in Patients with Advanced Hepatocellular Carcimona, with Better Tolerance and Similar Survival. Wiley.